Bird & Bird advised Fonds Patient Autonome and Uniqa Ventures on their €4 million financing round of Fizimed

International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.

The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.

The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner Carole Bodin and associate Pascaline Sagot, who advised on the corporate aspects, with partner Alexandre Vuchot and associate Caroline Arrighi-Savoie advising on the regulatory aspects.

The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.

News & Deals

More News & Deals
Deal Bird & Bird advises Castellum on strategic office lease to Outokumpu in Helsinki

Oct 06 2025

Read More
Deal Bird & Bird advises Castellum on strategic office redevelopment with Siemens in Finland

Oct 06 2025

Read More
Deal Bird & Bird advises CGS International Securities Singapore on Share Placement by Ever Glory United Holdings

Oct 06 2025

Read More
Deal Bird & Bird advises Saphine on the acquisition of the Cars Philibert Group

Oct 06 2025

Read More
Deal Bird & Bird advises Istithmar West Africa on signing a $300 million energy PPP contract in Mauritania

Oct 06 2025

Read More
News Bird & Bird maintains Mansfield Rule Certification for fourth year

Oct 03 2025

Read More